Maochang Liu - Publications

Astragaloside IV Mitigates Tacrolimus-Induced Chronic Nephrotoxicity by Regulating the mTOR-TFEB-GADD45α Pathway.

Journal: Journal of agricultural and food chemistry

Published: July 13, 2026

Concentration-to-dose ratio as a predictor of lacosamide efficacy in Chinese children with epilepsy: a single-center retrospective cohort study.

Journal: Frontiers in pharmacology

Published: January 16, 2026

Real-world safety profile of roflumilast: a pharmacovigilance analysis using FDA adverse event reporting system and Canada vigilance database.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: September 30, 2025

Correction: Astragaloside IV alleviates tacrolimus-induced chronic nephrotoxicity via p62-Keap1-Nrf2 pathway.

Journal: Frontiers in pharmacology

Published: September 21, 2025

Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition).

Journal: Translational pediatrics

Published: August 04, 2025

Influence of age and antiepileptic comedication on lacosamide concentrations in children with epilepsy: A retrospective cohort study.

Journal: PloS one

Published: May 27, 2025

Application of cell-derived vesicle-based biomimetic drug delivery system in tumor therapy.

Journal: Frontiers in pharmacology

Published: May 21, 2025

Population Pharmacokinetics and Model-Informed Precision Dosing of Clobazam Based on the Developmental and Genetic Characteristics of Children with Epilepsy.

Journal: Pharmaceutics

Published: May 01, 2025

Trends in anti-insomnia medication utilization among pediatric patients in nine cities in China: A real-world study (2016-2023).

Journal: Sleep medicine

Published: November 28, 2024

Population pharmacokinetics and dose optimization of ceftazidime in critically ill children.

Journal: Frontiers in pharmacology

Published: July 25, 2024

GADD45α is a direct target of TFEB and contributes to tacrolimus-induced chronic nephrotoxicity.

Journal: JCI insight

Published: June 03, 2024

Risk factors for thrombocytopenia associated with intravenous valproic acid therapy in pediatric patients undergoing neurosurgical operations.

Journal: Scientific reports

Published: May 16, 2024